EUVIMEDEUVIMED entdecken
Crossref

Safety Assessment of Levilactobacillus brevis KU15006: A Comprehensive Analysis of its Phenotypic and Genotypic Properties

Min-Gyu Lee, Min-Joo Kang, Suin Kim, Huijin Jeong, Dae-Kyung Kang, Hyun-Dong Paik, Young-Seo Park

Probiotics and Antimicrobial Proteins · 2025

DOI: 10.1007/s12602-024-10237-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Min-Gyu Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Levilactobacillus brevis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levilactobacillus brevis KU15006, isolated from kimchi, exhibits pathogen-antagonistic and anti-diabetic activities; however, the safety of this strain has not been assessed. In the present study, L. brevis KU15006 was evaluated to elucidate its safety as a probiotic strain using phenotypic and genotypic analyses. Its safety was assessed using a minimum inhibitory concentration test comprising nine antibiotics, 26 antibiotic resistance genes, a single conjugative element, virulence gene analysis, hemolysis, cell cytotoxicity, mucin degradation, and toxic metabolite production. L. brevis KU15006 exhibited equal or lower minimum inhibitory concentration for the nine antibiotics than the cut-off value established by the European Food Safety Authority. It did not harbor antibiotic resistance and virulence genes. L. brevis KU15006 lacked β-hemolysis, mucin degradation, cytotoxicity against Caco-2 cells, gelatin liquefaction, bile salt deconjugation, and toxic metabolite production abilities. Based on the results, L. brevis KU15006, which has antagonistic and anti-diabetic effects, could be marketed as a probiotic in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsLevilactobacillus brevisHumansCaco-2 CellsAnti-Bacterial AgentsMicrobial Sensitivity TestsGenotypePhenotypeFermented Foods

Stichwörter der Autor:innen

Levilactobacillus brevisAnti-diabetic activityPathogen antagonisticProbioticsSafety evaluation

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea.
  • Department of Animal Biotechnology, Dankook University, Cheonan, 31116, Republic of Korea.
  • Department of Food Science and Biotechnology of Animal Resource, Konkuk University, Seoul, 05029, Republic of Korea.
  • Department of Food Science and Biotechnology, Gachon University, Seongnam, 13120, Republic of Korea. ypark@gachon.ac.kr.

Zitieren

APA

Lee, M. G., Kang, M. J., Kim, S., Jeong, H., Kang, D. K., Paik, H. D., & Park, Y. S. (2025). Safety Assessment of Levilactobacillus brevis KU15006: A Comprehensive Analysis of its Phenotypic and Genotypic Properties. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-024-10237-z

Vancouver

Lee MG, Kang MJ, Kim S, Jeong H, Kang DK, Paik HD, et al. Safety Assessment of Levilactobacillus brevis KU15006: A Comprehensive Analysis of its Phenotypic and Genotypic Properties. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-024-10237-z

BibTeX
@article{Lee2025,
  author = {Lee, Min-Gyu and Kang, Min-Joo and Kim, Suin and Jeong, Huijin and Kang, Dae-Kyung and Paik, Hyun-Dong and Park, Young-Seo},
  title = {Safety Assessment of Levilactobacillus brevis KU15006: A Comprehensive Analysis of its Phenotypic and Genotypic Properties},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  doi = {10.1007/s12602-024-10237-z}
}
Kostenlos starten →